{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T05:28:09Z","timestamp":1734586089990,"version":"3.30.2"},"posted":{"date-parts":[[2024,12,18]]},"group-title":"In Review","reference-count":77,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T00:00:00Z","timestamp":1734480000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2024,12,17]]},"abstract":"<title>Abstract<\/title>\n        <p>Long non-coding RNAs (lncRNAs) and RNA N\u2076-methyladenosine (m<sup>6<\/sup>A) have been linked to leukemia drug resistance. However, whether and how lncRNAs and m<sup>6<\/sup>A coordinately regulate resistance remain elusive. Here, we show that many differentially expressed lncRNAs enrich m<sup>6<\/sup>A, and more lncRNAs tend to have higher m<sup>6<\/sup>A content in CML cells resistant to tyrosine kinase inhibitors (TKIs). We demonstrate broad clinical relevance of our findings, showing that upregulation of top-ranked lncRNAs (e.g., SENCR, PROX1-AS1, LN892) in TKI resistant cell lines occurs in CML patients at the diagnostic stage, blast crisis phase or not-responding to TKIs compared to chronic phase or TKI responders, respectively. Higher lncRNAs predict drug resistance and shorter survival duration. Knockdown of SENCR, PROX1-AS1 or LN892 restores TKI sensitivity. Mechanistically, upregulation of PROX1-AS1, SENCR and LN892 results from FTO-dependent m<sup>6<\/sup>A hypomethylation that stabilizes lncRNA transcripts, and empowers resistant cell growth through overexpression of PI3K signaling mediators (e.g., ITGA2, F2R, COL6A1). Treatment with PI3K inhibitor alpelisib eradicates resistant cells <italic>in vitro<\/italic> and <italic>in vivo<\/italic> with prolonged survival of leukemic mice through downregulation of F2R, ITGA2 and COL6A1. Thus, the lncRNA-m<sup>6<\/sup>A-PI3K cascade represents a new non-genetic predictor for drug resistance and poorer prognosis in cancer, and a pan-cancer mechanism underlying TKI resistance.<\/p>","DOI":"10.21203\/rs.3.rs-5663230\/v1","type":"posted-content","created":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T17:06:47Z","timestamp":1734541607000},"source":"Crossref","is-referenced-by-count":0,"title":["The RNA N\u2076-Methyladenosine Methylome Coordinates Long Non-Coding RNAs to Mediate Cancer Drug Resistance by Activating PI3K Signaling"],"prefix":"10.21203","author":[{"given":"Shujun","family":"Liu","sequence":"first","affiliation":[{"name":"The Metrohealth System, Case Western Reser"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"3040","DOI":"10.1038\/s41375-021-01436-6","article-title":"HUGO Gene Nomenclature Committee (HGNC) recommendations for the designation of gene fusions","volume":"35","author":"Bruford EA","year":"2021","unstructured":"Bruford EA, Antonescu CR, Carroll AJ, Chinnaiyan A, Cree IA, Cross NCP et al (2021) HUGO Gene Nomenclature Committee (HGNC) recommendations for the designation of gene fusions. Leukemia 35:3040\u20133043","journal-title":"Leukemia"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1586\/14737140.2016.1151356","article-title":"Imatinib mesylate in chronic myeloid leukemia: frontline treatment and long-term outcomes","volume":"16","author":"Stagno F","year":"2016","unstructured":"Stagno F, Stella S, Spitaleri A, Pennisi MS, Di Raimondo F, Vigneri P (2016) Imatinib mesylate in chronic myeloid leukemia: frontline treatment and long-term outcomes. Expert Rev Anticancer Ther 16:273\u2013278","journal-title":"Expert Rev Anticancer Ther"},{"key":"ref3","article-title":"Long-Term Outcomes of Imatinib Treatment for Chronic Myeloid Leukemia","author":"Hochhaus A","unstructured":"Hochhaus A, Larson RA, Guilhot F, Radich JP, Branford S, Hughes TP et al Long-Term Outcomes of Imatinib Treatment for Chronic Myeloid Leukemia. The New England journal of medicine 2017;376:917\u2009\u2013\u200927"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1182\/blood-2014-03-566323","article-title":"Prognosis for patients with CML and >\u200910% BCR-ABL1 after 3 months of imatinib depends on the rate of BCR-ABL1 decline","volume":"124","author":"Branford S","year":"2014","unstructured":"Branford S, Yeung DT, Parker WT, Roberts ND, Purins L, Braley JA et al (2014) Prognosis for patients with CML and >\u200910% BCR-ABL1 after 3 months of imatinib depends on the rate of BCR-ABL1 decline. Blood 124:511\u2013518","journal-title":"Blood"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1182\/blood-2010-03-277152","article-title":"Nilotinib is effective in patients with chronic myeloid leukemia in chronic phase after imatinib resistance or intolerance: 24-month follow-up results","volume":"117","author":"Kantarjian HM","year":"2011","unstructured":"Kantarjian HM, Giles FJ, Bhalla KN, Pinilla-Ibarz J, Larson RA, Gattermann N et al (2011) Nilotinib is effective in patients with chronic myeloid leukemia in chronic phase after imatinib resistance or intolerance: 24-month follow-up results. Blood 117:1141\u20131145","journal-title":"Blood"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.3109\/10428194.2012.737919","article-title":"Mechanisms responsible for nilotinib resistance in human chronic myeloid leukemia cells and reversal of resistance","volume":"54","author":"Camgoz A","year":"2013","unstructured":"Camgoz A, Gencer EB, Ural AU, Baran Y (2013) Mechanisms responsible for nilotinib resistance in human chronic myeloid leukemia cells and reversal of resistance. Leuk Lymphoma 54:1279\u20131287","journal-title":"Leuk Lymphoma"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1182\/blood-2007-03-066936","article-title":"Bcr-Abl kinase domain mutations, drug resistance, and the road to a cure for chronic myeloid leukemia","volume":"110","author":"O'Hare T","year":"2007","unstructured":"O'Hare T, Eide CA, Deininger MW (2007) Bcr-Abl kinase domain mutations, drug resistance, and the road to a cure for chronic myeloid leukemia. Blood 110:2242\u20132249","journal-title":"Blood"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.ccr.2009.09.028","article-title":"AP24534, a pan-BCR-ABL inhibitor for chronic myeloid leukemia, potently inhibits the T315I mutant and overcomes mutation-based resistance","volume":"16","author":"O'Hare T","year":"2009","unstructured":"O'Hare T, Shakespeare WC, Zhu X, Eide CA, Rivera VM, Wang F et al (2009) AP24534, a pan-BCR-ABL inhibitor for chronic myeloid leukemia, potently inhibits the T315I mutant and overcomes mutation-based resistance. Cancer Cell 16:401\u2013412","journal-title":"Cancer Cell"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/nrc3317","article-title":"Pushing the limits of targeted therapy in chronic myeloid leukaemia","volume":"12","author":"O'Hare T","year":"2012","unstructured":"O'Hare T, Zabriskie MS, Eiring AM, Deininger MW (2012) Pushing the limits of targeted therapy in chronic myeloid leukaemia. Nat Rev Cancer 12:513\u2013526","journal-title":"Nat Rev Cancer"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.ccr.2011.11.004","article-title":"Nilotinib and MEK inhibitors induce synthetic lethality through paradoxical activation of RAF in drug-resistant chronic myeloid leukemia","volume":"20","author":"Packer LM","year":"2011","unstructured":"Packer LM, Rana S, Hayward R, O'Hare T, Eide CA, Rebocho A et al (2011) Nilotinib and MEK inhibitors induce synthetic lethality through paradoxical activation of RAF in drug-resistant chronic myeloid leukemia. Cancer Cell 20:715\u2013727","journal-title":"Cancer Cell"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"470","DOI":"10.5581\/1516-8484.20110124","article-title":"Imatinib resistance: a review of alternative inhibitors in chronic myeloid leukemia","volume":"33","author":"Bitencourt R","year":"2011","unstructured":"Bitencourt R, Zalcberg I, Louro ID (2011) Imatinib resistance: a review of alternative inhibitors in chronic myeloid leukemia. Revista brasileira de hematologia e hemoterapia 33:470\u2013475","journal-title":"Revista brasileira de hematologia e hemoterapia"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"7519","DOI":"10.1158\/1078-0432.CCR-09-1068","article-title":"Mechanisms of Resistance to Imatinib and Second-Generation Tyrosine Inhibitors in Chronic Myeloid Leukemia","volume":"15","author":"Milojkovic D","year":"2009","unstructured":"Milojkovic D, Apperley J (2009) Mechanisms of Resistance to Imatinib and Second-Generation Tyrosine Inhibitors in Chronic Myeloid Leukemia. Clin cancer research: official J Am Association Cancer Res 15:7519\u20137527","journal-title":"Clin cancer research: official J Am Association Cancer Res"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1182\/blood-2012-05-431379","article-title":"BCR-ABL1 compound mutations in tyrosine kinase inhibitor-resistant CML: frequency and clonal relationships","volume":"121","author":"Khorashad JS","year":"2013","unstructured":"Khorashad JS, Kelley TW, Szankasi P, Mason CC, Soverini S, Adrian LT et al (2013) BCR-ABL1 compound mutations in tyrosine kinase inhibitor-resistant CML: frequency and clonal relationships. Blood 121:489\u2013498","journal-title":"Blood"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.hoc.2017.04.007","article-title":"Mechanisms of Resistance to ABL Kinase Inhibition in Chronic Myeloid Leukemia and the Development of Next Generation ABL Kinase Inhibitors","volume":"31","author":"Patel AB","year":"2017","unstructured":"Patel AB, O'Hare T, Deininger MW (2017) Mechanisms of Resistance to ABL Kinase Inhibition in Chronic Myeloid Leukemia and the Development of Next Generation ABL Kinase Inhibitors. Hematol Oncol Clin North Am 31:589\u2013612","journal-title":"Hematol Oncol Clin North Am"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.celrep.2014.05.048","article-title":"Perturbation of m6A writers reveals two distinct classes of mRNA methylation at internal and 5' sites","volume":"8","author":"Schwartz S","year":"2014","unstructured":"Schwartz S, Mumbach MR, Jovanovic M, Wang T, Maciag K, Bushkin GG et al (2014) Perturbation of m6A writers reveals two distinct classes of mRNA methylation at internal and 5' sites. Cell Rep 8:284\u2013296","journal-title":"Cell Rep"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/nchembio.1432","article-title":"A METTL3-METTL14 complex mediates mammalian nuclear RNA N6-adenosine methylation","volume":"10","author":"Liu J","year":"2014","unstructured":"Liu J, Yue Y, Han D, Wang X, Fu Y, Zhang L et al (2014) A METTL3-METTL14 complex mediates mammalian nuclear RNA N6-adenosine methylation. Nat Chem Biol 10:93\u201395","journal-title":"Nat Chem Biol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1038\/nchembio.687","article-title":"N6-methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO","volume":"7","author":"Jia G","year":"2011","unstructured":"Jia G, Fu Y, Zhao X, Dai Q, Zheng G, Yang Y et al (2011) N6-methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO. Nat Chem Biol 7:885\u2013887","journal-title":"Nat Chem Biol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.molcel.2012.10.015","article-title":"ALKBH5 is a mammalian RNA demethylase that impacts RNA metabolism and mouse fertility","volume":"49","author":"Zheng G","year":"2013","unstructured":"Zheng G, Dahl JA, Niu Y, Fedorcsak P, Huang CM, Li CJ et al (2013) ALKBH5 is a mammalian RNA demethylase that impacts RNA metabolism and mouse fertility. Mol Cell 49:18\u201329","journal-title":"Mol Cell"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1038\/cr.2014.151","article-title":"FTO-dependent demethylation of N6-methyladenosine regulates mRNA splicing and is required for adipogenesis","volume":"24","author":"Zhao X","year":"2014","unstructured":"Zhao X, Yang Y, Sun BF, Shi Y, Yang X, Xiao W et al (2014) FTO-dependent demethylation of N6-methyladenosine regulates mRNA splicing and is required for adipogenesis. Cell Res 24:1403\u20131419","journal-title":"Cell Res"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"11356","DOI":"10.1093\/nar\/gkx778","article-title":"N6-methyladenosine demethylase FTO targets pre-mRNAs and regulates alternative splicing and 3'-end processing","volume":"45","author":"Bartosovic M","year":"2017","unstructured":"Bartosovic M, Molares HC, Gregorova P, Hrossova D, Kudla G, Vanacova S (2017) N6-methyladenosine demethylase FTO targets pre-mRNAs and regulates alternative splicing and 3'-end processing. Nucleic Acids Res 45:11356\u201311370","journal-title":"Nucleic Acids Res"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/nature15377","article-title":"Dynamic m(6)A mRNA methylation directs translational control of heat shock response","volume":"526","author":"Zhou J","year":"2015","unstructured":"Zhou J, Wan J, Gao X, Zhang X, Jaffrey SR, Qian SB (2015) Dynamic m(6)A mRNA methylation directs translational control of heat shock response. Nature 526:591\u2013594","journal-title":"Nature"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/nrg3724","article-title":"Gene expression regulation mediated through reversible m(6)A RNA methylation","volume":"15","author":"Fu Y","year":"2014","unstructured":"Fu Y, Dominissini D, Rechavi G, He C (2014) Gene expression regulation mediated through reversible m(6)A RNA methylation. Nat Rev Genet 15:293\u2013306","journal-title":"Nat Rev Genet"},{"key":"ref23","article-title":"Dynamic m6A modification regulates local translation of mRNA in axons","author":"Yu J","unstructured":"Yu J, Chen M, Huang H, Zhu J, Song H, Zhu J et al Dynamic m6A modification regulates local translation of mRNA in axons. Nucleic acids research 2017"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.tig.2012.11.003","article-title":"Reversible RNA adenosine methylation in biological regulation","volume":"29","author":"Jia G","year":"2013","unstructured":"Jia G, Fu Y, He C (2013) Reversible RNA adenosine methylation in biological regulation. Trends Genet 29:108\u2013115","journal-title":"Trends Genet"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1101\/gad.262766.115","article-title":"RNA N6-methyladenosine methylation in post-transcriptional gene expression regulation","volume":"29","author":"Yue Y","year":"2015","unstructured":"Yue Y, Liu J, He C (2015) RNA N6-methyladenosine methylation in post-transcriptional gene expression regulation. Genes Dev 29:1343\u20131355","journal-title":"Genes Dev"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"E325","DOI":"10.1073\/pnas.1717794115","article-title":"ALKBH5-dependent m6A demethylation controls splicing and stability of long 3'-UTR mRNAs in male germ cells","volume":"115","author":"Tang C","year":"2018","unstructured":"Tang C, Klukovich R, Peng H, Wang Z, Yu T, Zhang Y et al (2018) ALKBH5-dependent m6A demethylation controls splicing and stability of long 3'-UTR mRNAs in male germ cells. Proc Natl Acad Sci USA 115:E325\u2013E33","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/nature12730","article-title":"N6-methyladenosine-dependent regulation of messenger RNA stability","volume":"505","author":"Wang X","year":"2014","unstructured":"Wang X, Lu Z, Gomez A, Hon GC, Yue Y, Han D et al (2014) N6-methyladenosine-dependent regulation of messenger RNA stability. Nature 505:117\u2013120","journal-title":"Nature"},{"key":"ref28","author":"Roundtree IA","year":"2017","unstructured":"Roundtree IA, Evans ME, Pan T, He C (2017) Dynamic RNA Modifications in Gene Expression Regulation. Cell. ;169:1187\u2009\u2013\u2009200"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/nature21355","article-title":"m(6)A-dependent maternal mRNA clearance facilitates zebrafish maternal-to-zygotic transition","volume":"542","author":"Zhao BS","year":"2017","unstructured":"Zhao BS, Wang X, Beadell AV, Lu Z, Shi H, Kuuspalu A et al (2017) m(6)A-dependent maternal mRNA clearance facilitates zebrafish maternal-to-zygotic transition. Nature 542:475\u2013478","journal-title":"Nature"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.cell.2015.05.014","article-title":"N(6)-methyladenosine Modulates Messenger RNA Translation Efficiency","volume":"161","author":"Wang X","year":"2015","unstructured":"Wang X, Zhao BS, Roundtree IA, Lu Z, Han D, Ma H et al (2015) N(6)-methyladenosine Modulates Messenger RNA Translation Efficiency. Cell 161:1388\u20131399","journal-title":"Cell"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ccell.2016.11.017","article-title":"FTO Plays an Oncogenic Role in Acute Myeloid Leukemia as a N6-Methyladenosine RNA Demethylase","volume":"31","author":"Li Z","year":"2017","unstructured":"Li Z, Weng H, Su R, Weng X, Zuo Z, Li C et al (2017) FTO Plays an Oncogenic Role in Acute Myeloid Leukemia as a N6-Methyladenosine RNA Demethylase. Cancer Cell 31:127\u2013141","journal-title":"Cancer Cell"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.ccell.2017.02.013","article-title":"m(6)A Demethylase ALKBH5 Maintains Tumorigenicity of Glioblastoma Stem-like Cells by Sustaining FOXM1 Expression and Cell Proliferation Program","volume":"31","author":"Zhang S","year":"2017","unstructured":"Zhang S, Zhao BS, Zhou A, Lin K, Zheng S, Lu Z et al (2017) m(6)A Demethylase ALKBH5 Maintains Tumorigenicity of Glioblastoma Stem-like Cells by Sustaining FOXM1 Expression and Cell Proliferation Program. Cancer Cell 31:591\u2013606 e6","journal-title":"Cancer Cell"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.cell.2017.11.031","article-title":"R-2HG Exhibits Anti-tumor Activity by Targeting FTO\/m(6)A\/MYC\/CEBPA Signaling","volume":"172","author":"Su R","year":"2018","unstructured":"Su R, Dong L, Li C, Nachtergaele S, Wunderlich M, Qing Y et al (2018) R-2HG Exhibits Anti-tumor Activity by Targeting FTO\/m(6)A\/MYC\/CEBPA Signaling. Cell 172:90\u2013105 e23","journal-title":"Cell"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1038\/s41556-018-0174-4","article-title":"m(6)A mRNA methylation regulates AKT activity to promote the proliferation and tumorigenicity of endometrial cancer","volume":"20","author":"Liu J","year":"2018","unstructured":"Liu J, Eckert MA, Harada BT, Liu SM, Lu Z, Yu K et al (2018) m(6)A mRNA methylation regulates AKT activity to promote the proliferation and tumorigenicity of endometrial cancer. Nat Cell Biol 20:1074\u20131083","journal-title":"Nat Cell Biol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/s41422-018-0034-6","article-title":"RNA N(6)-methyladenosine modification in cancers: current status and perspectives","volume":"28","author":"Deng X","year":"2018","unstructured":"Deng X, Su R, Weng H, Huang H, Li Z, Chen J (2018) RNA N(6)-methyladenosine modification in cancers: current status and perspectives. Cell Res 28:507\u2013517","journal-title":"Cell Res"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1038\/s41422-018-0097-4","article-title":"A dynamic N(6)-methyladenosine methylome regulates intrinsic and acquired resistance to tyrosine kinase inhibitors","volume":"28","author":"Yan F","year":"2018","unstructured":"Yan F, Al-Kali A, Zhang Z, Liu J, Pang J, Zhao N et al (2018) A dynamic N(6)-methyladenosine methylome regulates intrinsic and acquired resistance to tyrosine kinase inhibitors. Cell Res 28:1062\u20131076","journal-title":"Cell Res"},{"key":"ref37","author":"Sun Q","unstructured":"Sun Q, Hao Q, Prasanth KV Nuclear Long Noncoding RNAs: Key Regulators of Gene Expression. Trends in genetics: TIG 2018;34:142\u2009\u2013\u200957"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.gpb.2015.09.006","article-title":"Roles, Functions, and Mechanisms of Long Non-coding RNAs in Cancer","volume":"14","author":"Fang Y","year":"2016","unstructured":"Fang Y, Fullwood MJ (2016) Roles, Functions, and Mechanisms of Long Non-coding RNAs in Cancer. Genom Proteom Bioinform 14:42\u201354","journal-title":"Genom Proteom Bioinform"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.molmed.2018.01.001","article-title":"Therapeutic Targeting of Long Non-Coding RNAs in Cancer","volume":"24","author":"Arun G","year":"2018","unstructured":"Arun G, Diermeier SD, Spector DL (2018) Therapeutic Targeting of Long Non-Coding RNAs in Cancer. Trends Mol Med 24:257\u2013277","journal-title":"Trends Mol Med"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ncrna.2018.03.001","article-title":"Exploring the mechanisms behind long noncoding RNAs and cancer","volume":"3","author":"Balas MM","year":"2018","unstructured":"Balas MM, Johnson AM (2018) Exploring the mechanisms behind long noncoding RNAs and cancer. Non-coding RNA Res 3:108\u2013117","journal-title":"Non-coding RNA Res"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s12943-018-0821-1","article-title":"Linc00659, a long noncoding RNA, acts as novel oncogene in regulating cancer cell growth in colorectal cancer","volume":"17","author":"Tsai KW","year":"2018","unstructured":"Tsai KW, Lo YH, Liu H, Yeh CY, Chen YZ, Hsu CW et al (2018) Linc00659, a long noncoding RNA, acts as novel oncogene in regulating cancer cell growth in colorectal cancer. Mol Cancer 17:72","journal-title":"Mol Cancer"},{"key":"ref42","author":"Li Y","year":"2018","unstructured":"Li Y, Egranov SD, Yang L, Lin C (2018) Molecular Mechanisms of Long Noncoding RNAs-mediated Cancer Metastasis. Genes, chromosomes & cancer"},{"key":"ref43","article-title":"Roles of Long Noncoding RNAs in Recurrence and Metastasis of Radiotherapy-Resistant Cancer Stem Cells","author":"Chi HC","unstructured":"Chi HC, Tsai CY, Tsai MM, Yeh CT, Lin KH Roles of Long Noncoding RNAs in Recurrence and Metastasis of Radiotherapy-Resistant Cancer Stem Cells. Int J Mol Sci 2017;18","journal-title":"Int J Mol Sci"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1038\/s41588-018-0252-3","article-title":"Long noncoding RNA MALAT1 suppresses breast cancer metastasis","volume":"50","author":"Kim J","year":"2018","unstructured":"Kim J, Piao HL, Kim BJ, Yao F, Han Z, Wang Y et al (2018) Long noncoding RNA MALAT1 suppresses breast cancer metastasis. Nat Genet 50:1705\u20131715","journal-title":"Nat Genet"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"3192","DOI":"10.1038\/s41467-018-05495-9","article-title":"Systematic identification of non-coding pharmacogenomic landscape in cancer","volume":"9","author":"Wang Y","year":"2018","unstructured":"Wang Y, Wang Z, Xu J, Li J, Li S, Zhang M et al (2018) Systematic identification of non-coding pharmacogenomic landscape in cancer. Nat Commun 9:3192","journal-title":"Nat Commun"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"8027","DOI":"10.18632\/oncotarget.2469","article-title":"Correlation of long non-coding RNA expression with metastasis, drug resistance and clinical outcome in cancer","volume":"5","author":"Malek E","year":"2014","unstructured":"Malek E, Jagannathan S, Driscoll JJ (2014) Correlation of long non-coding RNA expression with metastasis, drug resistance and clinical outcome in cancer. Oncotarget 5:8027\u20138038","journal-title":"Oncotarget"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/nature19342","article-title":"m(6)A RNA methylation promotes XIST-mediated transcriptional repression","volume":"537","author":"Patil DP","year":"2016","unstructured":"Patil DP, Chen CK, Pickering BF, Chow A, Jackson C, Guttman M et al (2016) m(6)A RNA methylation promotes XIST-mediated transcriptional repression. Nature 537:369\u2013373","journal-title":"Nature"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.celrep.2015.06.053","article-title":"A Pooled shRNA Screen Identifies Rbm15, Spen, and Wtap as Factors Required for Xist RNA-Mediated Silencing","volume":"12","author":"Moindrot B","year":"2015","unstructured":"Moindrot B, Cerase A, Coker H, Masui O, Grijzenhout A, Pintacuda G et al (2015) A Pooled shRNA Screen Identifies Rbm15, Spen, and Wtap as Factors Required for Xist RNA-Mediated Silencing. Cell Rep 12:562\u2013572","journal-title":"Cell Rep"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1038\/nm.3981","article-title":"The emerging role of lncRNAs in cancer","volume":"21","author":"Huarte M","year":"2015","unstructured":"Huarte M (2015) The emerging role of lncRNAs in cancer. Nat Med 21:1253\u20131261","journal-title":"Nat Med"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"12181","DOI":"10.1007\/s13277-014-2526-4","article-title":"C-Myc-activated long noncoding RNA CCAT1 promotes colon cancer cell proliferation and invasion","volume":"35","author":"He X","year":"2014","unstructured":"He X, Tan X, Wang X, Jin H, Liu L, Ma L et al (2014) C-Myc-activated long noncoding RNA CCAT1 promotes colon cancer cell proliferation and invasion. Tumour biology: J Int Soc Oncodevelopmental Biology Med 35:12181\u201312188","journal-title":"Tumour biology: J Int Soc Oncodevelopmental Biology Med"},{"key":"ref51","article-title":"Long noncoding RNA ANRIL promotes non-small cell lung cancer cell proliferation and inhibits apoptosis by silencing KLF2 and P21 expression","author":"Nie FQ","unstructured":"Nie FQ, Sun M, Yang JS, Xie M, Xu TP, Xia R et al Long noncoding RNA ANRIL promotes non-small cell lung cancer cell proliferation and inhibits apoptosis by silencing KLF2 and P21 expression. Molecular cancer therapeutics 2015;14:268\u2009\u2013\u200977"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"5051","DOI":"10.1038\/s41467-019-12960-6","article-title":"Protein lysine 43 methylation by EZH1 promotes AML1-ETO transcriptional repression in leukemia","volume":"10","author":"Dou L","year":"2019","unstructured":"Dou L, Yan F, Pang J, Zheng D, Li D, Gao L et al (2019) Protein lysine 43 methylation by EZH1 promotes AML1-ETO transcriptional repression in leukemia. Nat Commun 10:5051","journal-title":"Nat Commun"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1038\/leu.2016.349","article-title":"Fatty acid-binding protein FABP4 mechanistically links obesity with aggressive AML by enhancing aberrant DNA methylation in AML cells","volume":"31","author":"Yan F","year":"2017","unstructured":"Yan F, Shen N, Pang JX, Zhang YW, Rao EY, Bode AM et al (2017) Fatty acid-binding protein FABP4 mechanistically links obesity with aggressive AML by enhancing aberrant DNA methylation in AML cells. Leukemia 31:1434\u20131442","journal-title":"Leukemia"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/nmeth.3317","article-title":"HISAT: a fast spliced aligner with low memory requirements","volume":"12","author":"Kim D","year":"2015","unstructured":"Kim D, Langmead B, Salzberg SL (2015) HISAT: a fast spliced aligner with low memory requirements. Nat Methods 12:357\u2013360","journal-title":"Nat Methods"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","article-title":"The Sequence Alignment\/Map format and SAMtools","volume":"25","author":"Li H","year":"2009","unstructured":"Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N et al (2009) The Sequence Alignment\/Map format and SAMtools. Bioinformatics 25:2078\u20132079","journal-title":"Bioinformatics"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","article-title":"featureCounts: an efficient general purpose program for assigning sequence reads to genomic features","volume":"30","author":"Liao Y","year":"2014","unstructured":"Liao Y, Smyth GK, Shi W (2014) featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics 30:923\u2013930","journal-title":"Bioinformatics"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","article-title":"edgeR: a Bioconductor package for differential expression analysis of digital gene expression data","volume":"26","author":"Robinson MD","year":"2010","unstructured":"Robinson MD, McCarthy DJ, Smyth GK (2010) edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26:139\u2013140","journal-title":"Bioinformatics"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/nar\/gkv007","article-title":"limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie ME","year":"2015","unstructured":"Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W et al (2015) limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res 43:e47","journal-title":"Nucleic Acids Res"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1182\/blood.2022016867","article-title":"Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN","volume":"140","author":"Dohner H","year":"2022","unstructured":"Dohner H, Wei AH, Appelbaum FR, Craddock C, DiNardo CD, Dombret H et al (2022) Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN. Blood 140:1345\u20131377","journal-title":"Blood"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"R16","DOI":"10.1186\/gb-2011-12-2-r16","article-title":"Genomewide characterization of non-polyadenylated RNAs","volume":"12","author":"Yang L","year":"2011","unstructured":"Yang L, Duff MO, Graveley BR, Carmichael GG, Chen LL (2011) Genomewide characterization of non-polyadenylated RNAs. Genome Biol 12:R16","journal-title":"Genome Biol"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"984","DOI":"10.6004\/jnccn.2009.0065","article-title":"NCCN clinical practice guidelines in oncology: chronic myelogenous leukemia","volume":"7","author":"O'Brien S","year":"2009","unstructured":"O'Brien S, Berman E, Borghaei H, Deangelo DJ, Devetten MP, Devine S et al (2009) NCCN clinical practice guidelines in oncology: chronic myelogenous leukemia. J Natl Compr Canc Netw 7:984\u20131023","journal-title":"J Natl Compr Canc Netw"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"W98","DOI":"10.1093\/nar\/gkx247","article-title":"GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses","volume":"45","author":"Tang Z","year":"2017","unstructured":"Tang Z, Li C, Kang B, Gao G, Li C, Zhang Z (2017) GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res 45:W98\u2013W102","journal-title":"Nucleic Acids Res"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"D917","DOI":"10.1093\/nar\/gkv1101","article-title":"BloodSpot: a database of gene expression profiles and transcriptional programs for healthy and malignant haematopoiesis","volume":"44","author":"Bagger FO","year":"2016","unstructured":"Bagger FO, Sasivarevic D, Sohi SH, Laursen LG, Pundhir S, Sonderby CK et al (2016) BloodSpot: a database of gene expression profiles and transcriptional programs for healthy and malignant haematopoiesis. Nucleic Acids Res 44:D917\u2013D924","journal-title":"Nucleic Acids Res"},{"key":"ref64","article-title":"m6A mRNA methylation facilitates resolution of naive pluripotency toward differentiation","author":"Geula S","year":"2015","unstructured":"Geula S, Moshitch-Moshkovitz S, Dominissini D, Mansour AA, Kol N, Salmon-Divon M et al (2015) m6A mRNA methylation facilitates resolution of naive pluripotency toward differentiation. Science","journal-title":"Science"},{"key":"ref65","article-title":"Meclofenamic acid selectively inhibits FTO demethylation of m6A over ALKBH5","author":"Huang Y","unstructured":"Huang Y, Yan J, Li Q, Li J, Gong S, Zhou H et al Meclofenamic acid selectively inhibits FTO demethylation of m6A over ALKBH5. Nucleic acids research 2015;43:373\u2009\u2013\u200984"},{"key":"ref66","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccell.2019.03.006","article-title":"Small-Molecule Targeting of Oncogenic FTO Demethylase in Acute Myeloid Leukemia","volume":"35","author":"Huang Y","year":"2019","unstructured":"Huang Y, Su R, Sheng Y, Dong L, Dong Z, Xu H et al (2019) Small-Molecule Targeting of Oncogenic FTO Demethylase in Acute Myeloid Leukemia. Cancer Cell ;35:677\u2009\u2013\u200991 e10","journal-title":"Cancer Cell"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/leu.2012.222","article-title":"Gab2 signaling in chronic myeloid leukemia cells confers resistance to multiple Bcr-Abl inhibitors","volume":"27","author":"Wohrle FU","year":"2013","unstructured":"Wohrle FU, Halbach S, Aumann K, Schwemmers S, Braun S, Auberger P et al (2013) Gab2 signaling in chronic myeloid leukemia cells confers resistance to multiple Bcr-Abl inhibitors. Leukemia 27:118\u2013129","journal-title":"Leukemia"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/sj.leu.2404523","article-title":"Multidrug resistance-associated protein 1 expression is under the control of the phosphoinositide 3 kinase\/Akt signal transduction network in human acute myelogenous leukemia blasts","volume":"21","author":"Tazzari PL","year":"2007","unstructured":"Tazzari PL, Cappellini A, Ricci F, Evangelisti C, Papa V, Grafone T et al (2007) Multidrug resistance-associated protein 1 expression is under the control of the phosphoinositide 3 kinase\/Akt signal transduction network in human acute myelogenous leukemia blasts. Leukemia 21:427\u2013438","journal-title":"Leukemia"},{"key":"ref69","volume-title":"Inactivation of Receptor Tyrosine Kinases Reverts Aberrant DNA Methylation in Acute Myeloid Leukemia","author":"Shen N","year":"2017","unstructured":"Shen N, Yan F, Pang J, Zhao N, Gangat N, Wu L et al (2017) Inactivation of Receptor Tyrosine Kinases Reverts Aberrant DNA Methylation in Acute Myeloid Leukemia. an official journal of the American Association for Cancer Research, Clinical cancer research"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1182\/blood-2009-03-210732","article-title":"A gene expression signature of CD34\u2009+\u2009cells to predict major cytogenetic response in chronic-phase chronic myeloid leukemia patients treated with imatinib","volume":"115","author":"McWeeney SK","year":"2010","unstructured":"McWeeney SK, Pemberton LC, Loriaux MM, Vartanian K, Willis SG, Yochum G et al (2010) A gene expression signature of CD34\u2009+\u2009cells to predict major cytogenetic response in chronic-phase chronic myeloid leukemia patients treated with imatinib. Blood 115:315\u2013325","journal-title":"Blood"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"eabg0809","DOI":"10.1126\/scitranslmed.abg0809","article-title":"Alpelisib administration reduced lymphatic malformations in a mouse model and in patients","volume":"13","author":"Delestre F","year":"2021","unstructured":"Delestre F, Venot Q, Bayard C, Fraissenon A, Ladraa S, Hoguin C et al (2021) Alpelisib administration reduced lymphatic malformations in a mouse model and in patients. Sci Transl Med 13:eabg0809","journal-title":"Sci Transl Med"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"11011","DOI":"10.1073\/pnas.0504952102","article-title":"Inhibition of drug-resistant mutants of ABL, KIT, and EGF receptor kinases","volume":"102","author":"Carter TA","year":"2005","unstructured":"Carter TA, Wodicka LM, Shah NP, Velasco AM, Fabian MA, Treiber DK et al (2005) Inhibition of drug-resistant mutants of ABL, KIT, and EGF receptor kinases. Proc Natl Acad Sci USA 102:11011\u201311016","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.molcel.2014.05.015","article-title":"Cancer epigenetics: tumor heterogeneity, plasticity of stem-like states, and drug resistance","volume":"54","author":"Easwaran H","year":"2014","unstructured":"Easwaran H, Tsai HC, Baylin SB (2014) Cancer epigenetics: tumor heterogeneity, plasticity of stem-like states, and drug resistance. Mol Cell 54:716\u2013727","journal-title":"Mol Cell"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.ccell.2016.03.009","article-title":"Intratumoral Heterogeneity of the Epigenome","volume":"29","author":"Mazor T","year":"2016","unstructured":"Mazor T, Pankov A, Song JS, Costello JF (2016) Intratumoral Heterogeneity of the Epigenome. Cancer Cell 29:440\u2013451","journal-title":"Cancer Cell"},{"key":"ref75","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.semcancer.2017.07.006","article-title":"Epigenetic dysregulation in chronic myeloid leukaemia: A myriad of mechanisms and therapeutic options","volume":"51","author":"Koschmieder S","year":"2018","unstructured":"Koschmieder S, Vetrie D (2018) Epigenetic dysregulation in chronic myeloid leukaemia: A myriad of mechanisms and therapeutic options. Semin Cancer Biol 51:180\u2013197","journal-title":"Semin Cancer Biol"},{"key":"ref76","article-title":"An Integrated Genome-wide CRISPRa Approach to Functionalize lncRNAs in Drug Resistance","author":"Bester AC","unstructured":"Bester AC, Lee JD, Chavez A, Lee YR, Nachmani D, Vora S et al An Integrated Genome-wide CRISPRa Approach to Functionalize lncRNAs in Drug Resistance. Cell 2018;173:649\u2009\u2013\u200964 e20"},{"key":"ref77","doi-asserted-by":"crossref","first-page":"e827","DOI":"10.1038\/cddis.2013.309","article-title":"PI3K\/mTOR pathway inhibitors sensitize chronic myeloid leukemia stem cells to nilotinib and restore the response of progenitors to nilotinib in the presence of stem cell factor","volume":"4","author":"Airiau K","year":"2013","unstructured":"Airiau K, Mahon FX, Josselin M, Jeanneteau M, Belloc F (2013) PI3K\/mTOR pathway inhibitors sensitize chronic myeloid leukemia stem cells to nilotinib and restore the response of progenitors to nilotinib in the presence of stem cell factor. Cell Death Dis 4:e827","journal-title":"Cell Death Dis"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-5663230\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-5663230\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T17:07:04Z","timestamp":1734541624000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-5663230\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,18]]},"references-count":77,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-5663230\/v1","relation":{},"subject":[],"published":{"date-parts":[[2024,12,18]]},"subtype":"preprint"}}